We applied KIRREL2 antibody to stain 96 Grp 3 MB with accessible whole tumor sections from the current transcriptome analysis cohort (screening set) and 76 samples from multi-institutional molecularly diagnosed Grp 3 MB cohort constructed on TMA sections and applied in previous study (independent/validation set) [15, 20]. This evidence concerns the gene KIRREL2 and neoplasm.